Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma.
نویسندگان
چکیده
BACKGROUND Radiofrequency thermal ablation is the first therapeutic option in percutaneous treatment of hepatocellular carcinoma but data on its long-term efficacy and safety are not conclusive. AIM This study reports a prospective survey on radiofrequency thermal ablation in north-east Italy. METHODS Data were collected on 401 patients with hepatocellular carcinoma (males 301, mean age: 68 years) treated by radiofrequency thermal ablation in 13 centres. Indication to treatment was: single nodule not eligible for surgery in 77% of patients, 2-3 nodes in 18% and multiple lesions in 5%. Mean size was 3 cm (1-8 cm). Treatment response was assessed at 1 month by spiral computerized tomography and then with ultrasound examination and new spiral computerized tomography. RESULTS Complete response was obtained in 67% of patients and in 27% response was 75-99%. Complete response raised to 77% in lesions smaller than 3 cm. The morbidity rate was 34%; the mortality was 0.5%, seeding was observed in four patients. Ten patients presented an unexpected rapid disease progression. CONCLUSION The above data show that by radiofrequency thermal ablation, complete response can be achieved only in about two-third of the cases, clearly less than expected, and that, beyond seeding, unexpected progression can be observed.
منابع مشابه
Percutaneous radiofrequency ablation of hepatocellular carcinoma compared to percutaneous ethanol injection in treatment of cirrhotic patients: an Italian randomized controlled trial.
AIM To compare 5-year survival of patients with a single hepatocellular carcinoma≤3 cm randomly assigned to receive percutaneous ethanol injection or radiofrequency ablation. PATIENTS AND METHODS A total of 285 patients (192 males, mean age 70 years), with a single hepatocellular carcinoma (mean diameter 2.2 cm) were randomly assigned to receive percutaneous ethanol injection (n=143) or radio...
متن کاملTumor Seeding after Fine Needle Aspiration Biopsy and Percutaneous Radiofrequency Thermal Ablation of Hepatocellular Carcinoma
Background: Radiofrequency thermal ablation (RFTA) has become a popular method of unresectable liver tumor ablation. However, its side effects should be paid attention to. Case Report: A 76year-old woman was found with an 8.4 ! 6.9 cm subcapsular mass in the left lateral liver lobe. She had cirrhosis with active hepatitis C. Well-differentiated hepatocellular carcinoma (HCC) was diagnosed based...
متن کاملImage-guided thermal ablation of hepatocellular carcinoma.
Hepatocellular carcinoma (HCC) is increasingly diagnosed at an early, asymptomatic stage owing to surveillance of high-risk patients. Given the complexity of the disease, multidisciplinary assessment of tumor stage, liver function, and physical status is required for proper therapeutic planning. Patients with early-stage HCC should be considered for any of the available curative therapies, incl...
متن کاملImmunotherapy for hepatocellular carcinoma following thermal ablation.
Hepatocellular carcinoma (HCC) is the fifth most common malignant disease and the third leading cause of cancer- associated deaths worldwide, and is characterized by a dismal prognosis. Despite the significant improvements achieved in liver transplantation, surgical resection, transcatheter arterial chemoembolization (TACE) and local ablative therapies such as percutaneous ethanol injection (PE...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Alimentary pharmacology & therapeutics
دوره 24 10 شماره
صفحات -
تاریخ انتشار 2006